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Introduction 
52Mn (t½ =5.59 d, β
+ = 29.6%, Eβmax = 0.58 MeV) 
has great potential as a long lived PET isotope 
for use in cell tracking studies, observation of 
immunologic response to disease states, or as an 
alternative to manganese-based MRI contrast 
agents. Its favorable max positron energy leads 
to superb imaging resolution, comparable to 
that of 18F.[1] 
 
Manganese is naturally taken up by cells via a 
multitude of pathways including the divalent 
metal transporter (DMT1), ZIP8, transferrin 
receptors (TfR), store-operated Ca2+ channels 
(SOC-Ca2+), and ionotropic glutamate receptor 
Ca2+ channels (GluR).[2] These natural transport 
mechanisms make 52Mn an attractive isotope for 
applications necessitating non-perturbative cell 
uptake. In particular, cell tracking is critical to 
the development and translation of stem cell 
therapies in regenerative medicine. Alternative-
ly, 52Mn could be used in immunotherapy tech-
niques such as adoptive cellular therapy (ACT) to 
evaluate the ability of external immune cells to 
reach their intended target.  
 
Material and Methods 
52Mn was produced by natCr(p,x)52Mn using 16 
MeV protons. The average thick target produc-
tion yield was 0.23 mCi/µA-h with less than 
0.25% co-production of 54Mn. Small amounts of 
51Cr were observed in the target, but were ab-
sent from the radiochemically separated prod-
uct.  
 
Target construction consisted of a water jet 
cooled chromium disc (3/4” diameter, 0.4” 
thick). Targets were purchased from Kamis Inc, 
and are 99.95% pure. Targets withstood beam 
currents of 30 µA with no visible aberration.  
 
Chromium targets were etched by concentrated 
HCl following bombardment. Mn2+ ions were 
extracted from 9M HCl to 0.8M trioctylamine in 
cyclohexane leaving the bulk chromium in the 
aqueous phase. After isolating the organic 
phase, 0.001M NH4OH was used to back-extract 
the Mn2+ ions to aqueous phase. This purifica-
tion cycle was conducted a total of three times 
for each 52Mn production.  
 
Results and Conclusion 
For a starting bulk chromium mass of 456 ± 
1 mg, a post-separation chromium mass of 5.35 
± 0.04 ng was measured by microwave plasma 
atomic emission spectrometry (MP-AES). This 
mass reduction corresponds to an average sepa-
ration factor of 440 for a single purification cy-
cle. Each purification cycle had a 52Mn recovery 
efficiency of 73 ± 7 % (n = 6), resulting in an 
overall separation efficiency of approximately 
35 %. These efficiencies and separation factors 
agree reasonably well with the work conducted 
by Lahiri et. al.[3] Prior to use, the product was 
passed through a C-18 Sep-Pak to remove any 
residual organic phase. 
 
After four target irradiations and etchings, some 
pitting became noticeable on the target face. 
These have not yet compromised the o-ring seal 
with the target deplater, but it is possible that 
target replacement after every 6–9 52Mn pro-
ductions will be necessary moving forward.  
 
Following the successful separation of 52Mn 
from chromium, in vitro experiments were con-
ducted to demonstrate the uptake of 52Mn by 
human stem cells and mouse tumor cells. A 
linear uptake response was observed as a func-
tion of the amount of activity exposed to the 
cells for both cell models. These experiments 
have shown great promise for 52Mn as a long-
lived PET isotope in cell tracking studies. Details 
will be presented.  
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